drugset / Trial / NCT06497049
Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and Ozempic®.
RandomizedParallel-groupOpen-labelTreatment
Summary
Study of comparative pharmacokinetics and biosimilarity of drugs containing semaglutide - GP40221 and Ozempic® in healthy volunteers.
Timeline
- Start
- 2023-06-30
- Primary completion
- 2024-05-05
- Completion
- 2024-05-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GP40221 | Unknown | 0.5 mg | Subcutaneous |
| Comparator | Semaglutide | Peptide | 0.5 mg | Subcutaneous |
Indications
No indication recorded.